10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001564590-16-023724`
Period End Date	20160630
Filing Date	20160809
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	arwr-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 75 Cash Flow Statement 59 Stockholders Equity 17

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$43.62M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$87.25M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.45M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.29M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.51M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$823.62K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$17.54M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$1.03M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	60.43M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	59.54M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$49.60M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$102.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.27M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	60.43M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.53M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	59.54M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.82M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$23.53M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$122.33K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$45.79K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$85.53M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$132.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.03M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.95M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.38M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.82M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.13M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$26.04K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.30M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.07M	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$216.65K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$217.55K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$144.44K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$15.90M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$14.84M	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$378.86K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$540.79K	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.86M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.86M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$2.24M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$142.45K	USD	Point-in-time
Note Payable	`LongTermNotesPayable`	$2.58M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$6.75M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$11.27M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 shares issued and outstanding as of June 30, 2016 and September 30, 2015	`PreferredStockValue`	$16.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 shares issued and outstanding as of June 30, 2016 and September 30, 2015	`PreferredStockValue`	$16.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 60,429,405 and 59,544,677 shares issued and outstanding as of June 30, 2016 and September 30, 2015, respectively	`CommonStockValue`	$151.91K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 60,429,405 and 59,544,677 shares issued and outstanding as of June 30, 2016 and September 30, 2015, respectively	`CommonStockValue`	$152.80K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$436.07M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$426.87M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-136.43K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.71K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-316.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-376.21M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$110.18M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$59.98M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$59.43M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$132.27M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$85.53M	USD	Point-in-time

Income Statement 75 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$127.08K	USD	3 Qtrs
REVENUE	`Revenues`	$123.75K	USD	1 Quarter
REVENUE	`Revenues`	$338.25K	USD	3 Qtrs
REVENUE	`Revenues`	$39.58K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$7.49M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$9.42M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$29.78M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$36.88M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$10.14M	USD	3 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$12.28M	USD	3 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$4.11M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$10.26M	USD	3 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.57M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.61M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.83M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.05M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.28M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$2.49M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$7.55M	USD	3 Qtrs
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$6.71M	USD	3 Qtrs
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$2.75M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$818.20K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$741.06K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.42M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.48M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$60.07M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$19.38M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$16.12M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$71.08M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-15.99M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-19.34M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-70.74M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-59.95M	USD	3 Qtrs
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$19.20K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$162.37K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$34.10K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$213.54K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$597.90K	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-113.36K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.45M	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$233.05K	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-104.71K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$482.90K	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$446.60K	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$3.55M	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$57.65K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-79.26K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-59.50M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-19.42M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-67.20M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-15.94M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-67.20M	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-19.42M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-59.50M	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-15.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-19.42M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-59.50M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-15.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-67.20M	USD	3 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-1.19	USD	3 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-1.00	USD	3 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.49M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.76M	shares	3 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	56.63M	shares	3 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.97M	shares	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.98K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$105.71K	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-90.62K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-65.95K	USD	3 Qtrs
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-19.51M	USD	1 Quarter
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-67.26M	USD	3 Qtrs
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-59.40M	USD	3 Qtrs
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-15.94M	USD	1 Quarter

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-67.20M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-19.42M	USD	1 Quarter
Net loss	`ProfitLoss`	$-59.50M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-15.94M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-113.36K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.45M	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$233.05K	USD	3 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-104.71K	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$10.14M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$6.71M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$7.55M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$818.20K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$741.06K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.42M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.48M	USD	3 Qtrs
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$945.11K	USD	3 Qtrs
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$201.35K	USD	3 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.52M	USD	3 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$887.43K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.33M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$913.66K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.16M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.73M	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$31.64K	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$24.25K	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-54.25M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-53.69M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.15M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.14M	USD	3 Qtrs
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$500.00	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$19.41M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$16.31M	USD	3 Qtrs
Cash paid for acquisitions	`PaymentsToAcquireAssetsInvestingActivities`	$10.00M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$8.28M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$15.16M	USD	3 Qtrs
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$162.82K	USD	3 Qtrs
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$160.16K	USD	3 Qtrs
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$634.19K	USD	3 Qtrs
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$2.29M	USD	3 Qtrs
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$313.75K	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$153.59K	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.49M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-37.60M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-45.26M	USD	3 Qtrs
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$43.62M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$87.25M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$43.62M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$87.25M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
Interest paid	`InterestPaid`	$8.91K	USD	3 Qtrs
Interest paid	`InterestPaid`	$11.15K	USD	3 Qtrs
Property and Equipment purchased through tenant improvement allowance financing	`PropertyAndEquipmentPurchasedThroughTenantImprovementAllowanceFinancing`	$4.85M	USD	3 Qtrs
Income Tax Credits Refunded	`ProceedsFromRefundableIncomeTaxCredits`	$1.37M	USD	3 Qtrs
Income Taxes Paid	`IncomeTaxesPaid`	$2.40K	USD	3 Qtrs
Income Taxes Paid	`IncomeTaxesPaid`	$2.40K	USD	3 Qtrs
Common Stock issued to Novartis for asset acquisition	`CommonStockIssuedForAssetAcquisition`	$25.00M	USD	3 Qtrs

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$59.43M	USD	Point-in-time
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$2.26M	USD	3 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$25.54K	USD	3 Qtrs
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	4,687.00	shares	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.55M	USD	3 Qtrs
Common stock- Restricted Stock Unit vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-634.19K	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.98K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$105.71K	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-90.62K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-65.95K	USD	3 Qtrs
Net loss for the nine months ended June 30, 2016	`ProfitLoss`	$-67.20M	USD	3 Qtrs
Net loss for the nine months ended June 30, 2016	`ProfitLoss`	$-19.42M	USD	1 Quarter
Net loss for the nine months ended June 30, 2016	`ProfitLoss`	$-59.50M	USD	3 Qtrs
Net loss for the nine months ended June 30, 2016	`ProfitLoss`	$-15.94M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$59.43M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.